http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20160028835-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2c7f445d213f26463744553736b33e24 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4704 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4725 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04 |
| filingDate | 2014-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f1be5f6d032660434ae825b609106dc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40068ae40b92ac6ab083f32fc70cfde3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8e0648fa8a5a9991940b4855376ceab http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ed5118b63e5e1c40b329a6960e918b6 |
| publicationDate | 2016-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20160028835-A |
| titleOfInvention | Pharmaceutical composition for preventing heart failure or dilated cardiomyopathy by doxorubicin comprising cilostazol as effective component |
| abstract | The present invention relates to a pharmaceutical composition comprising cilostazol as an active ingredient and for the prevention of heart failure or dilated cardiomyopathy which is specifically induced by doxorubicin. The pharmaceutical composition of the present invention can be used as an effective ingredient to reduce the side effects of doxorubicin when it is prescribed only doxorubicin while maintaining the effect of doxorubicin anticancer drug, And the effect of chemotherapy can be improved. |
| priorityDate | 2014-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 94.